The US Government keeps an online database, at clinicaltrials.gov, of clinical research studies for Mesothelioma cancer, but doesn't review or approve the safety and science of these trials. The website is maintained by the National Library of Medicine (NLM). The links below go to the clinical trial information on clinicaltrials.gov. Talk with your health care professional about possible risks and benefits before joining any studies.
Wed, 20 Aug 2025 00:00:00 EDT
Conditions: Malignant Mesothelioma; Mesothelioma
Interventions: Drug: iparomlimab and tuvonralimab (Dual PD-1/CTLA-4 blockade) + chemotherapy
Sponsors: National Cancer Center, China; Qilu Pharmaceutical Co., Ltd.; Affiliated Cancer Hospital of Zhengzhou University; Beijing Chest Hospital, Capital Medical University; The Affiliated Hospital of Inner Mongolia Medical University; Shaanxi Provincial Cancer Hospital
Not yet recruiting
Sun, 17 Aug 2025 00:00:00 EDT
Conditions: Mesothelioma; Mesothelioma; Lung; Mesotheliomas Pleural; Mesothelioma Malignant Advanced; Mesothelioma, Malignant
Interventions: Procedure: Partial Pleurectomy
Sponsors: University of Chicago
Not yet recruiting
Fri, 22 Aug 2025 00:00:00 EDT
Conditions: Lung Cancer; Thoracic Cancer; Lung Cancer, Nonsmall Cell; Adenocarcinoma; Squamous Cell Carcinoma; Large Cell Lung Cancer; Thymus Cancer; Mesothelioma
Interventions: Behavioral: Health-related quality of life and treatment outcome questionnaires; Genetic: (Tumor) tissue and other biomaterials; Procedure: Blood samples
Sponsors: Dutch Society of Physicians for Pulmonology and Tuberculosis
Recruiting
Wed, 27 Aug 2025 00:00:00 EDT
Conditions: Mesothelioma; Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Ovarian Neoplasms; Lung Neoplasms; Thymus Neoplasms; Colonic Neoplasms
Interventions: Device: mesothelin expression testing; Biological: TNhYP217 CAR T Cells; Drug: fludarabine; Drug: cyclophosphamide
Sponsors: National Cancer Institute (NCI)
Recruiting
Wed, 27 Aug 2025 00:00:00 EDT
Conditions: Mesothelioma; Malignant Mesothelioma (MM); Early-stage Mesothelioma; Subclinical Mesothelioma; BRCA1-Associated Protein-1 (BAP1) Mutations; Early-stage BAP1-associated Malignancies
Interventions: Drug: alrizomadlin
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
Wed, 27 Aug 2025 00:00:00 EDT
Conditions: Sarcoma; Small Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC); Mesothelioma; Pheochromocytoma/Paraganglioma (PPGL); Pancreatic Ductal Adenocarcinoma; Ovarian Cancer; Hepatocellular Carcinoma; Gastric Cancer; Cholangiocarcinoma; Bladder Cancer
Interventions: Drug: [18F]FAPI-74; Drug: [18F]FDG
Sponsors: National Cancer Institute (NCI)
Recruiting
Tue, 26 Aug 2025 00:00:00 EDT
Conditions: Mesothelioma; Malignant Mesothelioma (MM); Early-stage Mesothelioma; Subclinical Mesothelioma; BRCA1-Associated Protein-1 (BAP1) Mutations; Early-stage BAP1-associated Malignancies
Interventions: Drug: Decitabine/cedazuridine
Sponsors: National Cancer Institute (NCI)
Suspended
Thu, 21 Aug 2025 00:00:00 EDT
Conditions: Advanced Solid Tumor; NSCLC (Non-small Cell Lung Cancer); Renal Cancer; Mesothelioma; Non-Small Cell Squamous Lung Cancer; Non-small Cell Lung Adenocarcinoma
Interventions: Drug: NXP900
Sponsors: Nuvectis Pharma, Inc.
Recruiting
Wed, 20 Aug 2025 00:00:00 EDT
Conditions: High Grade Epithelial Ovarian Cancer; High Grade Serous Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer; Endometrial Cancer; Non-small Cell Lung Cancer; Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC); Mesothelioma; Breast Adenocarcinoma; Triple Negative Breast Cancer; Hormone Receptor-positive/Her2 Negative Breast Cancer; Platinum-resistant Ovarian Cancer (PROC); Platinum Sensitive Ovarian Cancer (PSOC); Primary Refractory Ovarian Cancer; Uterine Cancer
Interventions: Drug: Rina-S; Drug: Carboplatin; Drug: Bevacizumab; Drug: Pembrolizumab
Sponsors: Genmab
Recruiting
Tue, 26 Aug 2025 00:00:00 EDT
Conditions: Carcinoma, Non-Small-Cell Lung; Cutaneous Melanoma; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Nasopharyngeal Carcinoma; Carcinoma, Thymic; Anal Cancer; Mesothelioma; Esophagogastric Cancer; High Microsatellite Instability Colorectal Carcinoma; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
Interventions: Drug: KFA115; Drug: pembrolizumab
Sponsors: Novartis Pharmaceuticals
Recruiting
Menu